“…Article (Ye et al, 2017), cAMP signaling pathway (Ravnskjaer et al, 2016), PI3K-Akt signaling pathway (Zhou et al, 2019), MAPK signaling pathway (Yang et al, 2018), Wnt signaling pathway (Yao et al, 2018), NAFLD (Engin, 2017), type 1 diabetes mellitus (Ritchie et al, 2017), cGMP-PKG signaling pathway (Schwarz et al, 2018), FoxO signaling pathway (Cheng and White, 2011), type II diabetes mellitus (Samuel and Shulman, 2012), insulin secretion (Eto et al, 2002), and insulin signaling pathway (Consitt et al, 2009) as shown in Table 1. As hypermethylation in promoter regions is believed to silence the gene expression, it is reasonable to conclude that HG induces metabolic disorders via methylation of their key genes in the pathways, which were confirmed by analysis of mRNA levels as shown in Figure 5.…”